Abstract:
Bacterial nanocellulose (BNC) has been emerging as a biomaterial of considerable significance in
a number of industrial sectors because of its remarkable physico-chemical and biological characteristics.
High capital expenses, manufacturing costs, and a paucity of some well-scalable
methods, all of which lead to low BNC output in commercial scale, are major barriers that must
be addressed. Advances in production methods, including bioreactor technologies, static intermittent,
and semi-continuous fed batch technologies, and innovative outlay substrates, may be
able to overcome the challenges to BNC production at the industrial scale. The novelty of this
review is that it highlights genetic modification possibilities in BNC production to overcome
existing impediments and open up viable routes for large-scale production, suitable for realworld
applications. This review focuses on various production routes of BNC, its properties, and
applications, especially the major advancement in food, personal care, biomedical and electronic
industries.
